4DMedical Limited (ASX:4DX – Get Free Report) insider Andreas Fouras bought 1,850,914 shares of the firm’s stock in a transaction that occurred on Friday, January 16th. The stock was acquired at an average price of A$0.95 per share, for a total transaction of A$1,760,219.21.
Andreas Fouras also recently made the following trade(s):
- On Wednesday, January 21st, Andreas Fouras sold 263,157 shares of 4DMedical stock. The stock was sold at an average price of A$3.80, for a total transaction of A$999,996.60.
4DMedical Price Performance
The company has a quick ratio of 6.01, a current ratio of 1.78 and a debt-to-equity ratio of 7.22.
4DMedical Company Profile
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lungs ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
Featured Stories
- Five stocks we like better than 4DMedical
- The biggest scam in the history of gold markets in unwinding
- Buy This Stock at 9:30 AM on MONDAY!
- What Expenses Can Be Deducted From Capital Gains Tax?
- This stock gets a 94 out of 100
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for 4DMedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 4DMedical and related companies with MarketBeat.com's FREE daily email newsletter.
